Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use In Pregnancy To Autism Risk

2025-09-05 03:16:29

(MENAFN- AsiaNet News)

Tylenol maker Kenvue (KVUE) dropped to a one-year low in afternoon trade on Friday after reports surfaced that Health Secretary Robert F. Kennedy Jr. intends to link prenatal use of the drug to autism.

Kenvue's stock tumbled more than 11% to $18.11, its lowest level since August 2024. On Stocktwits, retail sentiment around the company fell into 'bearish' territory from 'neutral' a day ago.

According to a report by The Wall Street Journal, the Department of Health and Human Services (HHS) is likely to release its findings later this month. The upcoming Health Department report is expected to link autism risk to low folate levels and Tylenol use during pregnancy, people familiar with the matter told the publication.

Get updates to this developing story directly on Stocktwits.

Read also: Bessent Reportedly Says Fed Must Change Course To Preserve Independence

For updates and corrections, email newsroom[at]stocktwits[dot]com.

MENAFN05092025007385015968ID1110023763

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.